Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611 [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, tolerability and pharmacokinetic profile of levodopa delivered with continuous administration of ND0611 in Parkinson's di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ND0611 (ND0611)
• levodopa (levodopa)

Snippet

Sponsor: NeuroDerm Ltd. | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED